Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE

Brain iron elevation is implicated in Alzheimer’s disease (AD) pathogenesis, but the impact of iron on disease outcomes has not been previously explored in a longitudinal study. Ferritin is the major iron storage protein of the body; by using cerebrospinal fluid (CSF) levels of ferritin as an index, we explored whether brain iron status impacts longitudinal outcomes in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort. We show that baseline CSF ferritin levels were negatively associated with cognitive performance over 7 years in 91 cognitively normal, 144 mild cognitive impairment (MCI) and 67 AD subjects, and predicted MCI conversion to AD. Ferritin was strongly associated with CSF apolipoprotein E levels and was elevated by the Alzheimer’s risk allele, APOE-ɛ4. These findings reveal that elevated brain iron adversely impacts on AD progression, and introduce brain iron elevation as a possible mechanism for APOE-ɛ4 being the major genetic risk factor for AD. Brain-iron elevation is implicated in Alzheimer’s disease (AD), but the impact of the metal on disease outcomes has not been analysed in a longitudinal study. Here, the authors examine the association between the levels of ferritin, an iron storage protein, in the cerebrospinal fluid (CSF) of AD patients and show that CSF ferritin levels predict AD outcomes.

• Publication year

  2015

• Venue

  Nature Communications

• Publication date

  2015-05-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ncomms7760PMID 25988319PMCID 4479012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 7T T₂*-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease.

  2015cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• CSF Apo-E levels associate with cognitive decline and MRI changes

  2014cited by this paper
• Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults.

  2014cited by this paper
• Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease

  2014cited by this paper
• Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls

  2014cited by this paper
• Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals

  2014cited by this paper
• HFE gene variants, iron, and lipids: a novel connection in Alzheimer’s disease

  2014cited by this paper
• CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders

  2013cited by this paper
• The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

  2012cited by this paper
• Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease.

  2012cited by this paper
• Deducer: A Data Analysis GUI for R

  2012cited by this paper
• Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

  2012cited by this paper
• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI

  2011cited by this paper
• ggplot2: Elegant Graphics for Data Analysis

  2011cited by this paper
• Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

  2011cited by this paper
• An R Companion to Applied Regression

  2010cited by this paper
• Accumulation of intraneuronal Aβ correlates with ApoE4 genotype

  2010cited by this paper
• Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease.

  2010cited by this paper
• 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.

  2010cited by this paper
• Apolipoprotein E ablation decreases synaptic vesicular zinc in the brain

  2010cited by this paper
• ggplot2: Elegant Graphics for Data Analysis

  2010cited by this paper
• Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

  2009cited by this paper
• CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

  2009cited by this paper
• CSF biomarkers predict rate of cognitive decline in Alzheimer disease

  2009cited by this paper
• Hyperphosphorylation of tau protein in superficial CNS siderosis.

  2008cited by this paper
• The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods

  2008cited by this paper
• Adult-onset neurodegeneration with brain iron accumulation and cortical alpha-synuclein and tau pathology: a distinct clinicopathological entity.

  2007cited by this paper
• Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level.

  2006cited by this paper
• Cellular iron status influences the functional relationship between microglia and oligodendrocytes

  2006cited by this paper
• [P‐059]: Diabetes mellitus and risk of developing Alzheimer's dementia: Results from the Framingham study

  2005cited by this paper
• Secretion of Ferritin by Iron-laden Macrophages and Influence of Lipoproteins

  2004cited by this paper
• Brain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases

  2004cited by this paper
• Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging

  2003cited by this paper
• Diagnostic capability of CSF ferritin in children with meningitis.

  2003cited by this paper
• Iron (III) induces aggregation of hyperphosphorylated τ and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease

  2002cited by this paper
• Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease.

  2002cited by this paper
• The lipophilic iron compound TMH-ferrocene [(3,5,5-trimethylhexanoyl)ferrocene] increases iron concentrations, neuronal l-ferritin, and heme oxygenase in brains of BALB/c mice

  2002cited by this paper
• Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome

  2000cited by this paper
• Increased levels of intracellular iron in the brains of ApoE-deficient mice with closed head injury.

  2000cited by this paper
• Expression of ferritin protein and subunit mRNAs in normal and iron deficient rat brain.

  1999cited by this paper
• The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction.

  1999cited by this paper
• LINEAR AND NONLINEAR MIXED-EFFECTS MODELS

  1998cited by this paper
• Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

  1997cited by this paper
• Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms.

  1994cited by this paper
• Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy

  1994cited by this paper
• Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms.

  1994cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains

  1992cited by this paper
• Intramuscular desferrioxamine in patients with Alzheimer's disease.

  1991cited by this paper
• Brain iron and ferritin in Parkinson's and Alzheimer's diseases

  1990cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• For a list of recent papers see the backpages of this paper. Extended Beta Regression in R: Shaken, Stirred, Mixed, and Partitioned

  year unknowncited by this paper
• Ferritin Levels in the Cerebrospinal Fluid Predict Alzheimer's Disease Outcomes and Are Regulated by Apoe

  year unknowncited by this paper

• Ferritin-based photoimmunotherapeutic Trojan horse in situ vaccine for glioblastoma and brain metastases via meningeal lymphatic delivery

  2026cites this paper
• Griess's Reagent-Based Azo Compounds Ameliorate Multifaceted Toxicity and Ferroptosis in Alzheimer's Disease.

  2026cites this paper
• Ferroptosis in Alzheimer’s disease: molecular mechanisms and advances in therapeutic strategies

  2026cites this paper
• Induction of ferroptotic and amyloidogenic signatures linked to Alzheimer’s disease by chemically distinct air pollutants

  2026cites this paper
• Apolipoprotein E in Alzheimer’s disease: molecular insights and therapeutic opportunities

  2025cites this paper
• Genetic Markers of Postmortem Brain Iron

  2025cites this paper
• Hippocampal iron patterns in aging and mild cognitive impairment

  2025cites this paper
• Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications

  2025cites this paper
• Triggering ferroptosis in neurodegenerative diseases.

  2025cites this paper
• The multifaceted roles of apolipoprotein E4 in Alzheimer’s disease pathology and potential therapeutic strategies

  2025cites this paper
• Unraveling the inflammation–degeneration tangle in early MS: preliminary insights from ferritin, neurogranin, TREM2, and retinal ganglion cell layer

  2025cites this paper
• Extracellular vesicles released from endothelial cells of the blood-brain barrier mediate brain Iron accumulation during LPS-induced brain Inflammation

  2025cites this paper
• Iron Homeostasis Dysregulation, Oro-Gastrointestinal Microbial Inflammatory Factors, and Alzheimer’s Disease: A Narrative Review

  2025cites this paper
• The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer's disease: Research progress and insights.

  2025cites this paper
• CSF biomarkers of neuroinflammation are associated with regional atrophy

  2025cites this paper
• Multiple Demographic, Lifestyle, and Biological Factors Associated With Brain Iron Deposition in the Basal Ganglia: A Comprehensive Analysis of 25,980 UK Biobank Participants

  2025cites this paper
• A hemochromatosis allele that protects against Alzheimer's disease injury: A role for H-ferritin

  2025cites this paper
• THE EFFECTS OF IRON DEFICIENCY ON NEUROTRANSMISSION AND COGNITIVE FUNCTION: A LITERATURE REVIEW

  2025cites this paper
• Ferric Ammonium Citrate Reduces Claudin-5 Abundance and Function in Primary Mouse Brain Endothelial Cells

  2025cites this paper
• Iron on trial: recasting the role of iron in neurodegeneration.

  2025cites this paper
• Neuroferroptosis in health and diseases

  2025cites this paper
• APOE modulates ferroptosis to drive macrophage polarization toward the M2 type and enhance PTC migration and invasion.

  2025cites this paper
• Six‐month follow‐up of ARIA‐H and iron deposition in real‐world lecanemab therapy for Alzheimer's disease: Evidence from a Chinese 7T MRI cohort

  2025cites this paper
• Iron species in cerebrospinal fluid and dementia risk in subjects with mild cognitive impairment: a cohort study.

  2025cites this paper
• Emerging Links Between Ferroptosis and Neurodegeneration: Implications for Disease Mechanisms and Nutraceutical Interventions

  2025cites this paper
• Ferroptosis in Alzheimer's Disease: The Regulatory Role of Glial Cells.

  2025cites this paper
• Distinct brain alterations and neurodegenerative processes in cognitive impairment associated with post-acute sequelae of COVID-19

  2025cites this paper
• Low iron status and cognitive impairment in northern China community-dwelling older adults: a cross-sectional study

  2025cites this paper
• In defence of ferroptosis

  2025cites this paper
• Advances in Research on Neurotoxicity and Mechanisms of Manganese, Iron, and Copper Exposure, Alone or in Combination

  2025cites this paper
• ACSL4 in Alzheimer's disease: Pathogenetic mechanisms and potential therapeutic targets

  2025cites this paper
• Iron metabolism and ferroptosis in health and diseases: the crucial role of mitochondria in meta-bolically active tissues.

  2025cites this paper
• From Microbleeds to Iron: AI Prediction of Cerebrospinal Fluid Erythrocyte Load in Alzheimer’s Disease

  2025influential citation
• Carbon nanotube field-effect transistor immunosensor for the real-time detection of serum ferritin, a biomarker of Alzheimer's disease

  2025cites this paper
• Interpretable Machine Learning for Risk Stratification of Hippocampal Atrophy in Alzheimer’s Disease Using CSF Erythrocyte Load and Clinical Data

  2025cites this paper
• Increased iron deposition in putamen and substantia nigra correlates with cognitive function in cerebral small vessel disease: A quantitative susceptibility mapping study.

  2025cites this paper
• The association between individual and composite inflammation biomarkers and cognitive function

  2025cites this paper
• Oxidized phospholipids in ferroptosis, immunity and inflammation

  2025cites this paper
• Linking genetics to MRI-DTI: HFE polymorphism delays Alzheimer's disease white matter degeneration in APOE4 carriers

  2025cites this paper
• Phospholipids and peroxisomes in ferroptosis: the therapeutic target of acupuncture regulating vascular cognitive impairment and dementia

  2025cites this paper
• Role and mechanisms of ferroptosis in cognitive impairment: From molecular pathways to therapeutic targets (Review)

  2025cites this paper
• Correlation Between Dietary Nutrition and Glymphatic System Activity in Healthy Participants

  2025cites this paper
• Pulling back the mitochondria’s iron curtain

  2025cites this paper
• Associations Between Cortical Iron Accumulation and Memory in Patients With Amnestic Mild Cognitive Impairment and in Cognitively Normal Individuals

  2025cites this paper
• Ferroptosis and its contribution to cognitive impairment in Alzheimer's disease: mechanisms and therapeutic potential.

  2025cites this paper
• Targeting iron-associated protein Ftl1 in the brain of old mice improves age-related cognitive impairment

  2025cites this paper
• Ethanol Exacerbates the Alzheimer’s Disease Pathology in the 5xFAD Mouse Model

  2024cites this paper
• The interplay of transition metals in ferroptosis and pyroptosis

  2024cites this paper
• Neuronal regulated cell death in aging-related neurodegenerative diseases: key pathways and therapeutic potentials

  2024cites this paper
• The link between amyloid β and ferroptosis pathway in Alzheimer’s disease progression

  2024cites this paper
• A critical appraisal of ferroptosis in Alzheimer’s and Parkinson’s disease: new insights into emerging mechanisms and therapeutic targets

  2024cites this paper
• Exploratory Mass Spectrometry of Cerebrospinal Fluid from Persons with Autopsy-Confirmed LATE-NC

  2024cites this paper
• Cognitive impairment associated with individual and joint exposure to PM2.5 constituents in a Chinese national cohort

  2024cites this paper
• Association between Body Iron Status and Cognitive Task Performance in a Nationally Representative Sample of Older Adults

  2024cites this paper
• Examining iron‐related off‐target binding effects of 18F‐AV1451 PET in the cortex of Aβ+ individuals

  2024cites this paper
• Ferroptosis in health and disease

  2024cites this paper
• Iron Chelators and Alzheimer’s Disease Clinical Trials

  2024cites this paper
• Multiple Roles of Apolipoprotein E4 in Oxidative Lipid Metabolism and Ferroptosis During the Pathogenesis of Alzheimer’s Disease

  2024cites this paper
• Apolipoprotein E deficiency leads to the polarization of splenic macrophages towards M1 phenotype by increasing iron content

  2024cites this paper
• From Noise to Knowledge: Diffusion Probabilistic Model-Based Neural Inference of Gene Regulatory Networks

  2024cites this paper
• "Current and emerging drug therapies in Alzheimer's disease: A pathophysiological Perspective".

  2024cites this paper
• Iron accumulation/overload and Alzheimer's disease risk factors in the precuneus region: A comprehensive narrative review

  2024cites this paper
• Deferiprone in Alzheimer Disease: A Randomized Clinical Trial.

  2024cites this paper
• Ferroptosis and Cognitive Impairment: Unraveling the Link and Potential Therapeutic Targets.

  2024cites this paper
• PSL Chemical Biology Symposia: Recent Progress in Ferroptosis

  2024cites this paper
• Preparatory work for the update of the tolerable upper intake levels for iron

  2024cites this paper
• The role of iron transporters and regulators in Alzheimer's disease and Parkinson's disease: Pathophysiological insights and therapeutic prospects.

  2024cites this paper
• Iron Overload in Brain: Transport Mismatches, Microbleeding Events, and How Nanochelating Therapies May Counteract Their Effects

  2024cites this paper
• Iron homeostasis and post-hemorrhagic hydrocephalus: a review

  2024cites this paper
• Iron Deposition and Distribution Across the Hippocampus Is Associated with Pattern Separation and Pattern Completion in Older Adults at Risk for Alzheimer's Disease

  2024cites this paper
• Single nuclei transcriptomics in human and non-human primate striatum in opioid use disorder

  2024cites this paper
• Lifestyle, biological, and genetic factors related to brain iron accumulation across adulthood.

  2024cites this paper
• Ferroptosis is Involved in the Pharmacological Effect of Ginsenoside

  2024cites this paper
• Decursin ameliorates neurotoxicity induced by glutamate through restraining ferroptosis by up-regulating FTH1 in SH-SY5Y neuroblastoma cells.

  2024cites this paper
• The Irony of Iron: The Element with Diverse Influence on Neurodegenerative Diseases

  2024cites this paper
• Considerations for Using Neuroblastoma Cell Lines to Examine the Roles of Iron and Ferroptosis in Neurodegeneration

  2024cites this paper
• Iron imbalance in neurodegeneration

  2024cites this paper
• Ferritin Hinders Ferroptosis in Non-Tumorous Diseases: Regulatory Mechanisms and Potential Consequences.

  2024cites this paper
• International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis

  2024cites this paper
• Impaired cellular copper regulation in the presence of ApoE4

  2024cites this paper
• Programmed Death of Microglia in Alzheimer’s Disease: Autophagy, Ferroptosis, and Pyroptosis

  2023cites this paper
• The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer’s Disease: from the Perspective of Ferroptosis

  2023influential citation
• Might Diet, APOE-APOA1 Axis, and Iron Metabolism Provide Clues About the Discrepancy in Alzheimer’s Disease Occurrence Between Humans and Chimpanzees? A Bioinformatics-Based Re-Analysis of Gene Expression Data on Mice Fed with Human and Chimpanzee Diets

  2023cites this paper
• The Retromer Complex Protein VPS35 Modulates Iron Homeostasis by Regulating Hepcidin-Induced Ferroportin Degradation

  2023cites this paper
• Ferroptosis, Pyroptosis, and Cuproptosis in Alzheimer's Disease.

  2023cites this paper
• The Retromer Complex Protein VPS35 Modulates Iron Homeostasis by Regulating Hepcidin-Induced Ferroportin Degradation

  2023cites this paper
• Iron‐associated lipid peroxidation in Alzheimer's disease is increased in lipid rafts with decreased ferroptosis suppressors, tested by chelation in mice

  2023cites this paper
• Therapeutic Potential of Targeting Prokineticin Receptors in Diseases

  2023cites this paper
• The mechanism of ferroptosis and its related diseases

  2023cites this paper
• Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.

  2023cites this paper
• Research on Ferroptosis as a Therapeutic Target for the Treatment of Neurodegenerative Diseases.

  2023cites this paper
• Single nuclei transcriptomics in human and non-human primate striatum implicates neuronal DNA damage and proinflammatory signaling in opioid use disorder

  2023cites this paper
• Associations between sex, systemic iron and inflammatory status and subcortical brain iron

  2023cites this paper
• The Azalea Hypothesis of Alzheimer Disease: A Functional Iron Deficiency Promotes Neurodegeneration

  2023cites this paper
• Charting the Next Road Map for CSF Biomarkers in Alzheimer’s Disease and Related Dementias

  2023cites this paper
• Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes

  2023cites this paper
• Gut microbiota bridges the iron homeostasis and host health

  2023cites this paper
• Multimodal imaging of microstructural cerebral alterations and loss of synaptic density in Alzheimer's disease.

  2023cites this paper
• The old second messenger cAMP teams up with novel cell death mechanisms: potential translational therapeutical benefit for Alzheimer’s disease and Parkinson’s disease

  2023cites this paper
• A natural polyphenol activates and enhances GPX4 to mitigate amyloid-β induced ferroptosis in Alzheimer's disease

  2023cites this paper